<unk>  targets the cellular pathway known as PD-1 (protein found on the body’s immune cells and some cancer cells) so it acts as a checkpoint inhibitor.
Cemiplimab
Regdanvimab
Atoltivimab
Sotrovimab
Lirentelimab
Obiltoxaximab
Nirsevimab
Odesivimab